Skip to content

Usefulness of HPV genotyping after cervical conization in patients with cervical intraepithelial neoplasia

Usefulness of HPV genotyping after cervical conization in patients with cervical intraepithelial neoplasia - HPV genotyping after conization

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000039970
Enrollment
150
Registered
2020-04-01
Start date
2020-01-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical intraepithelial neoplasia

Interventions

None listed

Sponsors

Jichi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Histologically confirmed CIN2 or 3 Conization for the first time

Exclusion criteria

Exclusion criteria: Expecting women Obvious invasive cancer

Design outcomes

Primary

MeasureTime frame
Recurrence rate by HPV genotyping test result before and after cervical conization

Countries

Japan

Contacts

Public ContactTAKAHIRO KOYANAGI

Jichi Medical University Research Support Section

rinri@jichi.ac.jp0285587550

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026